| MAPK1 (Erk2) | MAPK | CMGC | 8ao6 | A | B | ~{n}-(1~{h}-indazol-5-ylmethyl)ethanamide | Human | 14396 | 0.48 | |
| MAPK1 (Erk2) | MAPK | CMGC | 8ao2 | A | B | ~{n}-(1~{h}-indazol-5-ylmethyl)propanamide | Human | 14394 | 0.47 | |
| MAPK1 (Erk2) | MAPK | CMGC | 8ao2 | A | A | ~{n}-(1~{h}-indazol-5-ylmethyl)propanamide | Human | 14415 | 0.47 | |
| ROCK1 | DMPK | AGC | 3v8s | A | | 1-(1h-indazol-5-yl)-3-(2-phenylethyl)urea | Human | 2716 | 0.40 | |
| PRKACA (PKACa) | PKA | AGC | 3l9n | A | | (2s)-n~1~-[5-(1h-indazol-5-yl)-1,3,4-thiadiazol-2-yl]-3-(4-methylphenyl)propane-1,2-diamine | Human | 5292 | 0.42 | |
| MAPK1 (Erk2) | MAPK | CMGC | 8ao5 | A | B | ~{n}-(1~{h}-indazol-5-ylmethyl)ethanesulfonamide | Human | 14400 | 0.43 | |
| RPS6KA3-b (RSK2-b) | RSKb | CAMK | 4jg7 | A | A | (2r)-2-cyano-3-[3-(1h-pyrrolo[2,3-b]pyridin-3-ylcarbonyl)phenyl]propanamide | Human | 1496 | 0.44 | |
| RPS6KA3-b (RSK2-b) | RSKb | CAMK | 4jg8 | A | B | (2s)-2-cyano-n-(1-hydroxy-2-methylpropan-2-yl)-3-[3-(3,4,5-trimethoxyphenyl)-1h-indazol-5-yl]propanamide | Human | 1498 | 0.42 | |
| RPS6KA3-b (RSK2-b) | RSKb | CAMK | 4jg7 | A | B | (2r)-2-cyano-3-[3-(1h-pyrrolo[2,3-b]pyridin-3-ylcarbonyl)phenyl]propanamide | Human | 1494 | 0.44 | |
| RPS6KA3-b (RSK2-b) | RSKb | CAMK | 4jg6 | A | | (2s)-2-cyano-3-(1h-indazol-5-yl)propanamide | Human | 1495 | 1.00 | |
| RPS6KA3-b (RSK2-b) | RSKb | CAMK | 4jg8 | A | A | (2s)-2-cyano-n-(1-hydroxy-2-methylpropan-2-yl)-3-[3-(3,4,5-trimethoxyphenyl)-1h-indazol-5-yl]propanamide | Human | 1497 | 0.42 | |
| RPS6KA5-b (MSK1-b) | RSKb | CAMK | 7up7 | A | A | (2s)-2-cyano-n-(1-hydroxy-2-methylpropan-2-yl)-3-[3-(3,4,5-trimethoxyphenyl)-1h-indazol-5-yl]propanamide | Human | 14318 | 0.42 | |
| MAPK1 (Erk2) | MAPK | CMGC | 8ao6 | A | A | ~{n}-(1~{h}-indazol-5-ylmethyl)ethanamide | Human | 14397 | 0.48 | |
| MAPK1 (Erk2) | MAPK | CMGC | 8ao3 | A | B | 2-chloranyl-~{n}-(1~{h}-indazol-5-ylmethyl)ethanamide | Human | 14414 | 0.49 | |
| RPS6KA5-b (MSK1-b) | RSKb | CAMK | 7up6 | A | B | (e)-3-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)-2-cyanoacrylamide bound form | Human | 14354 | 0.46 | |
| RPS6KA5-b (MSK1-b) | RSKb | CAMK | 7up6 | A | A | (e)-3-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)-2-cyanoacrylamide bound form | Human | 14353 | 0.46 | |
| MAPK1 (Erk2) | MAPK | CMGC | 8ao3 | A | A | 2-chloranyl-~{n}-(1~{h}-indazol-5-ylmethyl)ethanamide | Human | 14386 | 0.49 | |
| MAPK1 (Erk2) | MAPK | CMGC | 8ao5 | A | A | ~{n}-(1~{h}-indazol-5-ylmethyl)ethanesulfonamide | Human | 14392 | 0.43 | |
| RPS6KA5-b (MSK1-b) | RSKb | CAMK | 7up7 | A | B | (2s)-2-cyano-n-(1-hydroxy-2-methylpropan-2-yl)-3-[3-(3,4,5-trimethoxyphenyl)-1h-indazol-5-yl]propanamide | Human | 14317 | 0.42 | |
| ROCK1 | DMPK | AGC | 3v8s | D | | 1-(1h-indazol-5-yl)-3-(2-phenylethyl)urea | Human | 2692 | 0.40 | |
| ROCK1 | DMPK | AGC | 3v8s | C | | 1-(1h-indazol-5-yl)-3-(2-phenylethyl)urea | Human | 2702 | 0.40 | |
| ROCK1 | DMPK | AGC | 3v8s | B | | 1-(1h-indazol-5-yl)-3-(2-phenylethyl)urea | Human | 2709 | 0.40 | |
